Heidrich Daiane, González Gloria M, Pagani Danielle M, Ramírez-Castrillón Mauricio, Scroferneker Maria Lucia
Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul. Rua Ramiro Barcelos, 2400 - 2nd floor, Porto Alegre CEP: 90035-003, Brazil.
Department of Microbiology, Facultad de Medicina, Universidad Autónoma de Nuevo León, Madero y Aguirre Pequeño, Col. Mitras Centro, Monterrey, N.L. C.P. 64460, Mexico.
Med Mycol Case Rep. 2017 Apr 7;16:25-27. doi: 10.1016/j.mmcr.2017.04.002. eCollection 2017 Jun.
We report a case of chromoblastomycosis in lesions on the chest and foot. Itraconazole was chosen as the initial treatment for this patient, who was followed up for 8 months before becoming noncompliant. The pathogenic fungal species was identified as by ITS region sequencing. analyses indicate that the fungus was sensitive to posaconazole and itraconazole. This report presents as a new agent of chromoblastomycosis and raises the hypothesis that this species could be more resistant to some antifungals than .
我们报告了一例胸部和足部病变的着色芽生菌病病例。伊曲康唑被选为该患者的初始治疗药物,在其不依从治疗前对其进行了8个月的随访。通过ITS区域测序鉴定出致病真菌种类。分析表明该真菌对泊沙康唑和伊曲康唑敏感。本报告提出[具体真菌种类未明确写出]作为着色芽生菌病的一种新病原体,并提出该菌种可能比[对比的菌种未明确写出]对某些抗真菌药物更具耐药性的假设。